Influenza viral RNA transcription in vitro is primed by capped RNA fragments cleaved from capped RNAs by a viral endonuclease. The present study was undertaken to determine whether the specificities of the viral endonuclease and transcriptase observed in in vitro studies are also observed in the infected cell. The NS (nonstructural) gene of influenza WSN virus was cloned in pBR322 by using a double-stranded DNA containing a cDNA copy of both virion RNA (vRNA) and in vivo viral mRNA. We determined the 5' terminal sequence of the particular NS viral mRNA molecule which was cloned and also the 5 1 terminal sequences of the entire population of in vivo NS viral mRNAs synthesized in two different cell lines. For the latter determination we used a restriction fragment from the cloned DNA for the reverse transcriptase-catalyzed extension of total in vivo viral mRNA. The results indicate that in vivo and in vitro viral RNA~~transcription are similar in two important respects: (TJ transcription initiates not with an A residue directed by the 3' terminal U of the vRNA, but with a G residue directed by the 3' penultimate C of the vRNA; and (ii) capped RNA fragments containing a 3' terminal A residue are preferentially used as primers, thereby generating an AG sequence in the viral mRNA complementary to the 3' terminal UC of the vRNA. Actually, for in vivo transcription, a subset of A-terminated capped fragments, namely tfibse containing a 3' penultimate C residue, are the preferred primers. The latter specificity had not been observed in previous in vttro studies.
INTRODUCTION
Influenza virus employs a unique mechanism for the i n i t i a t i o n of the synthesis of i t s messenger RNA (mRNA). The basic mechanism was worked out in in v i t r o studies using the virion-associated transcriptase. I t was shown that heterologous capped RNAs strongly stimulate viral RNA transcription in v i t r o (1,2,3). The capped RNAs are cleaved 10-13 nucleotides from their 5 1 ends by a virion-associated cap-dependent endonuclease, generating fragments with 3' terminal hydroxyl groups (4) . Cleavage occurs preferentially, or almost exclusively, at purine residues, yielding A-and G-terminated capped fragments. Most of these capped RNA fragments were shown to be linked to one or more G residues in transcriptase reactions containing labeled GTP as the only ribonucleoside triphosphate, indicating that they are most likely the actual primers initiating viral RNA transcription (4). The results suggested that this G incorporation is directed by the penultimate C residue at the 3 1 end of the eight virion RNA (vRNA) templates (4), all of which have the sequence 3' UCG (5). Consistent with this, a C residue was incorporated onto the primer fragments after the G. Because the 3' terminal U residue of the vRNA apparently does not direct the incorporation of an A residue, the only way that an A residue could appear in the viral mRNA opposite the 3' terminal U of the vRNA would be if the primer fragment used to initiate mRNA synthesis had an A residue at its 3' terminus. It was concluded that this is what in fact usually occurs, because primer fragments with a 3' terminal A residue were used more effectively for G incorporation than fragments with a 3' terminal G residue (4). Consequently, influenza viral mRNAs synthesized in vitro would contain an AGC sequence complementary to the 3' end of the vRNA.
The situation concerning in vivo viral RNA transcription, however, is much less clear. Priming by capped RNAs also occurs in vivo because the viral mRNAs synthesized in the infected cell contain 10-15 nucleotides at their 5 1 ends, including the cap, which are not viral-coded (6,7,8). This host-donated sequence is heterogeneous for most of its length (7,8), indicating that multiple different host capped RNAs almost certainly serve as primers. The question is how much heterogeneity occurs at the position opposite the 3' terminal U of the vRNA. A few of the viral mRNAs coding for various viral proteins apparently contain a base other than A at this position (7, 8) , indicating that transcription in vivo, like that in vitro, most probably initiates not with an A residue directed by the 3' terminal U of the vRNA template, but rather with a G residue directed by the 3 1 penultimate C of the vRNA. One report (8) has claimed that the position in in vivo viral mRNA (coding for the viral membrane protein) opposite the 3' terminal U of the vRNA is completely heterogeneous, consistent with a complete lack of preference for the utilization of A-terminated host cell capped RNA fragments as primers in the infected cell. This would mean that in vivo the viral endonuclease cleaves capped host cell RNAs at both purines and pyrimidines and that all of the resulting fragments are used indiscriminately as primers by the viral transcriptase. In contrast, another study (19) has presented some evidence suggesting that the in vivo viral mRNA coding for the NS2 viral protein contains predominantly an A at the position opposite the 3' terminal U of the vRNA.
It is important to resolve this issue in order to determine whether the specificities of the viral endonuclease and transcriptase are the same in vitro and in vivo. Further, if an A residue were predominantly found at the position opposite the 3' terminal U of the vRNA, then it would be conceivable that the same initiation step could be used for the synthesis of both viral mRNA and the full-length transcripts that are the putative templates for vRNA synthesis. Here, we will show conclusively that there is a strong preference for A-terminated capped RNA fragments as primers in vivo as well in vitro. Further, we unexpectedly found that in vivo there is also a preference for the utilization of fragments containing a 3' penultimate C residue, a specificity which was not observed previously in 2IL vitro studies.
MATERIALS AND METHODS
RNA Preparations. Virion RNA (vRNA) was extracted from purified influenza WSN virus as previously described (10,11). Viral mRNA synthesized in infected MDCK (canine kidney) or chicken embryo fibroblast (CEF) cells was isolated as described previously (10,11). Briefly, cycloheximide (100 pg/ml) was added to the infected cells at 2.5 hours after infection to increase the amount of viral mRNA produced, the cells were collected three hours later, and the cytoplasmic poly A(+) RNA was isolated by two successive chromatographies on oligo dT cellulose.
Cloning of the NS viral RNA segment. DNA complementary to the vRNA segments was synthesized using reverse transcriptase and a dodecanucleotide primer AGCAAAAGCAGG (Collaborative Research, Inc.) which is complementary to the 3' end of all the vRNA segments. Complementary DNA (cDNA) to poly A(+) RNA from the cytoplasm of infected MDCK cells (prepared as described above) was synthesized using oligo dT 12 _io as primer. The total cDNA of the two preparations was fractionated by electrophoresis on a 3% polyacrylamide gel containing 7 M urea. The cDNAs corresponding to the smallest genome segment (NS segment) were eluted, and the two complementary cDNAs were annealed to each other for 3 hours at 68 C in 0.3 M NaCl, 1 mM EDTA, 10 mM Hepes, pH 7.8. This strategy for obtaining viral double-stranded DNA has been employed by others (12,13,14) . The double-stranded NS DNA was tailed with about 30 dC residues by incubation with calf thymus terminal deoxynucleotidyl transferase in the presence of 50 mM Hepes, pH 7.8, 1 mM MnCl 2 , 100 yM dCTP, 1 mM DTT, 50 mM KC1, 100 yg/ml BSA. The plasmid pBR322 was digested with Pst I, and tailed with about 20-30 dG residues using terminal transferase. The NS double-stranded DNA (tailed with C's) and the pBR322 (tailed with G's) were annealed to each other for 3 hours at 68 C, and after a two-fold dilution with water was used directly to transform E. coli HB 101. Transformants were selected for tetracycline resistance and ampicillin s e n s i t i v i t y , and were screened by the colony f i l t e r hybridization method (15) using P-labeled cDNA (to vRNA) as probe. The transformant containing the largest insert at the Pst I site was shown to contain NS-specific sequences by a Southern blot (16) using P-labeled NS cDNA as probe. DNA isolated from this clone (NS-10) was used for a l l the experiments described here.
Sequencing and primer extension. DNA sequence analysis was carried out using the Maxam and Gilbert method (17) . A 18 base pair (bp), Hind I I IBam HI restriction fragment of the DNA from the NS-10 clone (see Figure 1 ) was used as primer for the reverse transcriptase-catalyzed extension of in vivo NS viral mRNA. After complete digestion of NS-10 DNA with Hind I I I followed by treatment with calf intestine alkaline phosphatase, the DNA fragments were labeled at their 5' ends with P using T4 polynucleotide kinase, and were then cleaved with Bam HI. This digest was electrophoresed on a 10% polyacrylamide g e l , and the 18 bp fragment was eluted and purified
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Hind I I I I Alu I Ban HI by DEAE-cellulose chromatography. This DNA fragment and the viral mRNA preparation were dissolved in 10 yl of water, and were heated at 100 C for 2 minutes and fast-cooled in a dry ice-ethanol bath. After addition of deionized formamide to 80%, the mixture was hybridized at 42 C for 4 hours in 0.4 M NaCl, 2 mM EDTA, 10 mM Pipes, pH 6.4 in a final volume of 100 u l . After four ethanol precipitations, the primer was extended for 60 minutes at 37 C with 80 units of reverse transcriptase in 50 mM Tris -HC1, pH 8.3, 50 mM KC1, 10 mM MgC1 2 , 10 mM DTT and 600 yM of each of the deoxynucleoside triphosphates in a final volume of 400 u l . The reaction was terminated by the addition of NaOH to 0.1 N, the mixture was incubated for 10 minutes at 68 C and then neutralized. DNA was isolated by phenol-chloroform extraction, Sephadex G-50 chromatography, and ethanol precipitation. After heating and fast-cooling, the extended primer was separated from the unextended primer by electrophoresis on a 10% polyacrylamide gel containing 9 M urea. The extended primer was eluted, chromatographed on DEAE-cellulose and sequenced.
T G C G G A C A T G C C A A A G A A A G C A A T C T A C C T G A A A G C T T G A C A C A G T G T T T G G A A C G C C T G T A C G G T T T C T T T C G T T A G A T G G A C T T T C G A A C T G T G T C A C A A A C C T

Hph I p TG
T C C A T T A T G TfClT T T G T C A C C C T G C T T T T G C A G G T A A T A C AIGJA A A C A G T G G G A C G A A A A C G
G G A C G A A A A C G C C U G C U U U U G C Host Primer
C G A G G C C T T C C G 3' G C T C C G G A A G G C 5'
G C U C C G G
RESULTS
Sequence of the cloned NS DNA corresponding to the 5' end of the viral mRNA. The estimated size of the influenza virus-specific Pst I insert of the NS-10 clone as determined by electrophoresis on a 4% acrylamide gel in comparison to Hae I I I restriction fragments of i j >X174 DNA is 950 bp (data not shown). This is consistent with this insert being a full-length copy of the NS viral gene segment. The entire 5 1 end of the viral mRNA is certainly represented in the Pst I insert, as shown by the sequence of one of the three Taq I restriction fragments of the insert (Figure 1 ). This sequence indicates the existence of several r e s t r i c t i o n enzyme sites and hence several possible restriction fragments suitable for primer extension of NS viral mRNA. The 18 bp Hind III-Bam HI r e s t r i c t i o n fragment was chosen for primer extension.
I t is of interest to note that in the viral-coded region this part of the NS sequence of the WSN influenza A strain d i f f e r s in only 7 nucleotides (shown by boxes) from the sequence of the closely related virus strain A/PR/8/34 (18) . I f the same frequency of differences occurred in the rest of the NS gene, there would only be about a 4% difference in nucleotide sequence between the NS genes of WSN and PR8 virus. This would be the smallest difference in nucleotide sequence between NS genes of different influenza virus strains (18) .
The NS-10 insert also contained additional nonviral nucleotides at i t s end (the end corresponding to the 5 1 end of the viral mRNA). These additional nucleotides almost certainly represent the host cell primer sequence found at the 5' end of one of the in vivo NS viral mRNA molecules. In the original DNA duplex inserted into pBR322 the nucleotides in the nonviral region were unpaired: clear that the primer sequences containing G or U at this position are minor species. In particular, the U-containing species should be very minor. The v i r i o n endonuclease in v i t r o cleaves predominately, usually exclusively, at purine residues (4). In f a c t , cleavage at U residues occurred only under special circumstances, such as when the ribopolymer m GpppGmC(U) n was used as primer (19) . I t is therefore l i k e l y that the only reason that the Uterminated host primer sequence shown in Figure 5 was produced is that this particular capped cellular RNA did not contain a purine residue at the usual viral endonuclease cleavage sites (10 to 13 nucleotides from the cap).
This would be expected to be an infrequent event in the c e l l . All of the clones except one (the HA clone-Udorn-MDCK cells) contain a cellular primer sequence 13 nucleotides long or less. These are the expected lengths because the v i r i o n endonuclease in v i t r o has been shown to cleave at a pos- 
C G U U U U C G U C C VRNA G C A A A A G C A G G NS (WSN-MDCK) G C A A A A G C A G G NS (udorn-MDCK) G C A A A A G C A G G NS (udorn-MDCK) G C A A A A G C A G G NS (udorn-MDCK) G C A A A A G C A G G HA (udorn-MOCK) G C A A A A G C A G G HA (udorn-MDCK) G C A A A A G C A G G • " (FPV-CEF)
virus-coded i t i o n 10 to 13 nucleotides from the cap (4) and because reverse transcriptase may not always copy the entire 5 1 terminus of the in vivo viral mRNA segments. The 5' sequence of the one longer primer sequence in Figure 5 contains two copies of a 5-nucleotide sequence (AGCAA) complementary to the 3' end of the vRNA, suggesting that copying errors occurred during the cloning procedure. Errors in the region of the nonviral sequence are not unexpected because the nucleotides in this region were unpaired in the original duplex inserted into pBR322, thereby requiring f a i t h f u l completion of the double-strands by bacterial DNA repair enzymes.
In v i t r o and in vivo viral RNA transcription are also similar in the preferential, or almost exclusive, use of A-terminated capped RNA fragments as primers to i n i t i a t e transcription. In this paper we present the evidence establishing that A-terminated host capped fragments are predominantly used as primers to i n i t i a t e viral RNA transcription in vivo. Using an appropriate restriction fragment from the NS-10 DNA clone as a primer for the reverse transcriptase-catalyzed extension of the entire population of in vivo NS viral mRNAs from two different cell l i n e s , an A was almost exclusively found in the viral mRNAs opposite the 3 1 terminal U of the vRNA.
This result is in direct conflict with the results of Caton and Robertson (8) . These workers used primer extension to analyze the 5 1 ends of the M (membrane protein) viral mRNAs (of fowl plague virus) synthesized in CEF and concluded that there was complete heterogeneity in these mRNAs at the position opposite the 3' terminal U of the vRNA. However, with their method of sequencing by dideoxy-chain termination, many artefactual bands occurred in several lanes of the sequencing g e l , and as a consequence i t was not possible to read unambiguously the 5' sequence in the viral mRNAs that is complementary to the 3' end of vRNA. I t is therefore l i k e l y that the heterogeneity observed in the viral mRNAs at the position opposite the 3' terminal U of vRNA was an artefact. Support for our data comes from another group of workers. In a study in which the nucleotide sequence overlap of the NS 1 and NS 2 viral mRNAs (both coded by the NS viral gene segment) (Udorn virus strain) was analyzed by primer extension, Lamb and Lai (9) claimed that there was predominantly an A opposite the 3' terminal U of the vRNA. However, because the sequencing gel was run in order to read internal positions of the mRNA, i t was d i f f i c u l t to read the terminal positions of the mRNA, and consequently some heterogeneity at the position opposite the 3' terminal U of the vRNA was not convincingly ruled out. After we completed the experiments reported here, we learned that Lamb and coworkers (personal communication) analyzed the 5' ends of the M viral mRNAs (Udorn virus strain) synthesized in HeLa cells and found predominantly an A in these viral mRNAs at the position opposite the 3' terminal U of the vRNA. Thus, this is a general phenomenon, occurring with at least two different viral strains, with at least two viral mRNA segments and in at least three different cell lines. The fact that A-terminated host capped RNA fragments are almost exclusively used as primers means that an AGC is generated in the viral mRNAs complementary to the 3' end of the vRNA. It is then conceivable that the same initiation step is used for the synthesis of both viral mRNA and the full-length transcripts that are the putative templates for vRNA synthesis. The latter transcripts, which comprise only a small fraction of the total viral transcripts in the infected cell, do not have poly A at their 3' end or a cap structure and host-derived sequence at their 5' end (20, 21) . The synthesis of these transcripts requires the synthesis of one or more viruscoded proteins. One function of this protein(s) would be to block the termination of transcription (17-22 nucleotides from the 5 1 end of vRNA) that occurs during viral mRNA synthesis (22) . It is not yet known how the f u l llength transcripts are initiated. One possibility is that the newly synthesized virus-coded protein(s) enable the transcriptase to initiate RNA synthesis without a primer at the 3' terminal U of vRNA (instead of at the 3 1 penultimate C as occurs during viral mRNA synthesis). If this were the case, these transcripts would have a pppA 5' terminus. At present, the number of phosphates at the 5' end of the full-length transcripts is not known (21) . The other alternative is that the same host cell RNA-primed initiation step is used for the full-length transcripts, followed by removal of the host-derived sequence by nucleolytic cleavage. Clearly, this would be feasible only i f there were predominantly an A residue opposite the 3' terminal U of the vRNA, as we have found, thereby resulting in the proper AGC... sequence at the 5' end of the full-length transcripts.
Our results indicate that not all A-terminated host capped RNA fragments are used as primers for viral RNA transcription in vivo, but rather only those fragments with a CA 3' terminus are principally used. This specificity had not been observed in previous studies of transcription in vitro catalyzed by the virion-associated transcriptase as none of the capped RNA primers used in these in vitro experiments contained a CA sequence 10 to 13 nucleotides from the cap. Several possibilities emerge from this result. One possibility is that in the infected cell the in-
